At Ichilov, highly qualified doctors specialize in hematology and methods for combating conditions involving the accumulation of malignant lymphoma cells in the blood, lymph nodes, and bone marrow. This contributes to a deeper understanding of the specifics of occurrence and effective treatment of lymphoblastic lymphoma in Israel.
The medical center's policy is based on personalized treatment planning that corresponds to the unique characteristics of each specific case. Treatment for lymphoblastic lymphoma involves collaboration among specialists from various fields: hematologists, oncologists, radiologists, surgeons, and other physicians, ensuring a comprehensive approach to evaluating each patient.
The medical center has significant experience working with international patients. The clinic is equipped with modern medical equipment that allows for accurate diagnosis and quality therapy. The latest advancements in cancer treatment are utilized here, including targeted therapy and immunotherapy.
About the Disease
Lymphoblastic lymphoma, also known as lymphoblastic lymphoma, is a rare and rapidly progressing subtype of non-Hodgkin lymphoma. The pathology is characterized by the malignant growth of lymphoblasts – immature cells of the lymphatic system. It can develop from B-lymphocytes or T-lymphocytes and is classified accordingly as B-lymphoblastic or T-lymphoblastic lymphoma.
The exact causes of lymphoblastic lymphoma remain unknown. However, there are risk factors that may increase the likelihood of developing this disease:
- genetic disorders or mutations,
- exposure to radiation or carcinogenic chemicals,
- immunodeficiency states or diseases,
- weakened immune system, for example, in patients undergoing organ transplantation or immunosuppressive therapy.
Signs of lymphoblastic lymphoma are largely similar to the symptoms of other types of lymphomas:
- enlargement of lymph nodes without painful sensations,
- increased fatigue and weakness,
- weight loss without apparent reason,
- fever, sweating, especially at night,
- frequent infections,
- bleeding or bruising without significant reasons,
- bone and joint pain,
- enlargement of the liver or spleen.
Send your records — an Ichilov physician will reply within 1–2 days, free of charge.
Treatment Methods for the Disease
Accurate diagnosis and prompt treatment are critically important for improving prognosis. The classical therapeutic strategy typically includes chemotherapy, which may be supplemented with radiotherapy or stem cell transplantation, depending on the stage of the disease and the overall condition of the patient.
Chemotherapy
Chemotherapy is the primary treatment strategy for lymphoblastic lymphoma. It is based on antitumor drugs that are administered intravenously or orally. Treatment is usually divided into several phases:
- induction chemotherapy aimed at destroying most cancer cells and achieving remission;
- consolidation (intensification) aimed at destroying residual cancer cells;
- maintenance chemotherapy, which may continue for several years and is aimed at preventing disease recurrence.
Radiation Therapy
Radiotherapy may be used to destroy residual cancer cells, especially in areas where tumors are detected. Radiation is also used to prevent the spread of the disease to the central nervous system, which is a common complication of lymphoblastic lymphoma.
At Ichilov, linear accelerators TrueBeam and Lunac are utilized as part of the comprehensive treatment of lymphoblastic lymphomas. These are state-of-the-art equipment models for conducting precise and highly effective radiotherapy. They provide increased accuracy in targeting the beam at the tumor, minimizing damage to surrounding healthy tissues and organs, real-time visualization, shorter radiation therapy sessions, and modulation of beam intensity during the procedure. These linear accelerators are suitable for performing stereotactic radiation therapy (SRT) and stereotactic radiosurgery (SRS) in one or several sessions, which is particularly valuable for small or hard-to-reach tumors.
Stem Cell Transplantation
Autologous stem cell transplantation may be considered at certain stages of treatment, especially after achieving the first remission. Initially, high-dose chemotherapy or radiation therapy is performed to destroy cancer cells, and then the patient's own, previously collected, healthy stem cells are returned to restore the bone marrow.
Monoclonal Antibody Therapy
Monoclonal antibodies may be used to treat certain types of lymphoblastic lymphoma if it originates from B-cells.
This method uses specialized drugs that specifically bind to antigens on the surface of cancerous B-cells. This leads to the destruction of tumor cells by inducing immune responses and activating apoptosis (programmed cell death). This approach allows for more precise targeting of therapy at affected cells, minimizing impact on healthy tissues and reducing overall treatment toxicity.
Intrathecal Chemotherapy
This method involves the administration of chemotherapy drugs directly into the cerebrospinal fluid through a puncture in the spinal area. This approach is used for the treatment or prevention of lymphoma metastasizing to the central nervous system (CNS). The method ensures delivery of high concentrations of the drug to the brain and spinal cord, bypassing the blood-brain barrier.
Targeted Drugs and Immunotherapy
New drugs targeting specific molecular targets of lymphoma cells are used in the therapy of lymphoblastic lymphoma. An example of such a target is the Philadelphia chromosome (translocation between chromosomes 9 and 22), for which tyrosine kinase inhibitors are used.
Such drugs may also be prescribed in cases of disease recurrence or resistance to standard treatment methods such as chemotherapy or radiotherapy. Sometimes the method is considered as a first-line therapy if standard treatment is unsuitable for any reason.
Immunotherapy drugs help enhance the body's own defenses against cancer cells, for example, by blocking immune checkpoint pathways.
- Stem Cell Treatment
- Radiation Therapy
- Chemotherapy
- Monoclonal Therapy
- Targeted Chemotherapy
Diagnostic Methods for the Disease
Doctors at Ichilov have extensive experience in diagnosing and treating diseases from a heterogeneous group arising from lymphatic and reticuloendothelial system cells. The diagnosis of lymphoblastic lymphoma includes several stages: physical, laboratory, and instrumental studies. Typically, tests and processing of results take 3 days.
First Day
The doctor reviews the medical history and collects a complete patient history. Conducts a thorough physical examination and compiles a list of the most appropriate laboratory and instrumental studies.
Second Day
Laboratory Tests
- Complete blood count to check the number of various types of blood cells.
- Biochemical blood tests.
- Immunophenotyping (flow cytometry) for accurate classification of the disease.
- Cytogenetic analyses and FISH (fluorescence in situ hybridization) studies examining chromosomal changes.
- Molecular genetic studies (PCR, polymerase chain reaction).
Instrumental Studies
- Computed tomography (CT) of lymph nodes, abdominal organs, and chest for the presence of neoplasms.
- Magnetic resonance imaging (MRI) for detailed imaging,
- PET-CT (positron emission tomography combined with CT). Allows assessment of the metabolic activity of tissues and identification of areas with increased activity of cancer cells.
- Echo-cardiography or MUGA scan. To assess the function of the heart muscle.
Biopsy and histological studies.
- Lymph node biopsy.
- Bone marrow trepanobiopsy.
Third Day
The combination of diagnostic procedures gives doctors insight into the nature, characteristics, and stage of lymphoblastic lymphoma. A team of doctors works on interpreting the results at Ichilov: oncologist-hematologist, radiologist, histopathologist, radiation therapist, transplantologist, immunologist, geneticist, and other specialists. This collegial approach allows for a quick, accurate, and comprehensive assessment of the disease's progression in a specific patient and the development of the most effective treatment plan.
- Computed Tomography
- Magnetic Resonance Imaging (MRI)
- Diagnosis — PET CT
- Blood Biochemistry
How Much Does Treatment Cost
The cost of treatment at Ichilov depends on the stage and characteristics of the disease at the time of admission to the clinic. The price is influenced by the number and complexity of diagnostic studies, the need to involve narrow specialists and experts from related fields.
Call a medical consultant to find out what is needed to prepare a preliminary estimate of the treatment program, how the diagnosis is made, where to find ratings and reviews, how much it costs, and how the stay at the clinic is organized. You can ask any questions in the online chat or describe your problem in a special feedback form on the website.
Advantages of Treating Lymphoblastic Lymphoma in Israel
- High level of specialization and individual approach
- Advanced equipment
- Innovative treatment methods
- Interdisciplinary consultations
- Experience in treating foreign patients, comfort of stay, organizational and language support
In Israel, research is conducted in the field of cellular markers and clinical trials of new drugs, methods, and approaches to treating pathologies associated with malignant lymphoma cells accumulating in the bone marrow, blood, and lymph nodes. You can order a video consultation with a doctor who has practical experience in treating such diseases directly from home. Via Zoom or Skype, the doctor will discuss the most effective therapeutic approaches and recommend further actions in your specific situation.